Oncologist can approach IMU to run Clinical Trails from their own practice. Once safety and toxicity is proven in a drug, IMU can apply to the FDA to have the small Oncologist sponsored trials approved.
But it’s likely Breakthrough Therapy will negate the need for this.
Ann: FDA clears Imugene IND for onCARlytics first-in-class study, page-149
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.9¢ |
Change
-0.002(2.82%) |
Mkt cap ! $505.0M | |||
| Open | High | Low | Value | Volume |
| 7.1¢ | 7.1¢ | 6.9¢ | $698.8K | 10.11M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 1480211 | 6.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.0¢ | 1674762 | 38 |
View Market Depth
| Last trade - 15.50pm 28/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.9¢ |
Change
-0.002 ( 1.15 %) |
||||
| Open | High | Low | Volume | ||
| 7.0¢ | 7.0¢ | 6.9¢ | 3175836 | ||
| Last updated 15.59pm 28/05/2024 ? | |||||
| IMU (ASX) Chart |